Magle Chemoswed
Magle Chemoswed Holding Reports Financial Results For Second Quarter 2023
MAR
Today, on 18 Julyl 2023, Magle Chemoswed Holding AB (publ) has published its interim report for Q2 2023.
APR-JUN 2023 KEY INDICATORS
- Net sales amounted to 38.1 MSEK (35.5).
- EBITDA equalled 9.5 MSEK (7.7).
- Operating profit (EBIT) is 6.3 MSEK (4.2)
- Profit after tax amounted to 4.7 MSEK (3.8)
- Earnings per share SEK 0,4 (0,4) per share
JAN-JUN 2023 KEY INDICATORS
- Net sales amounted to 76.7 MSEK (65.7).
- EBITDA equalled 17.0 MSEK (15.4).
- Operating profit (EBIT) is 10.6 MSEK (8.8)
- Profit after tax amounted to 7.6 MSEK (7.9)
- Earnings per share SEK 0,7 (0,7) per share
“In the second quarter, we expanded our project portfolio, strong clinical data for SmartPAN® was presented to key opinion leaders, and total revenues from our CDMO business and DSM-based products increased by 7.4 percent compared to the corresponding period last year.” says Justin Pierce, CEO of Magle Group.
The full report is available at https://maglegroup.com/financial-reports/
Datum | 2023-07-18, kl 08:30 |
Källa | MFN |
![](https://static.allaaktier.se/ads/hand-waving-2.png)